
EXAS
Exact Sciences Corp
Obter previsão
Obtenha previsões de ações IA no seu dispositivo
Sobre esta empresa
Exact Sciences Corp. develops and commercializes non-invasive molecular screening tests for the early detection and prevention of colorectal cancer. The DNA-based test helps identify precancerous conditions and the presence of cancer by detecting genetic mutations in colon cells.

